Pharmafile Logo

Are you suffering from templatitis?

May 16, 2017 |  

- PMLiVE
At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is required to move a business forward, templates can be the death of progress.

Duncan Ferguson, managing director of the Lucid Strategic Consultancy, calls this – templatitis. Especially in a market as complex and diverse as pharma, templated approaches to business strategy can stand in the way of fresh thinking. “It is no wonder that the challenge of reflecting our heterogenous strategic plans in homogenous templates is causing such traumatic symptoms”, posits Duncan. 

In Duncan’s recent blog for PMLIVE he proposes three approaches to combat templatitis, which you can read more about here.

 If your business suffers from templatitis and is in need of a strategic overhaul, you can get in touch with Duncan at duncan@lucid-group.co.uk or on +44 (0)1494 755707

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications

From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.

Lucid Group shines at the Communiqué Awards

Lucid Group’s commitment to be a leader in medical education was recognised at the Communiqué Awards 2016 in London last night, where the agency received three awards, including being highly...

Developing Medical Education That Advances Patient Outcomes

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...

Future-proofing with a comprehensive talent development strategy

Lucid Group is an award-winning group of specialist medical education companies. Over the years, Lucid has developed a strong culture of empowerment, thought-leadership, entrepreneurship and passion to improve outcomes for...

Lucid reach the shortlist for Communiqué 2016 in SIX categories

Lucid Group are celebrating the news that for the first time they have been shortlisted in six different categories at this year’s Communiqué awards.  The categories are:Excellence in Communications of...

Lucid Co-founder and COO discusses the changing landscape of healthcare communications

In May’s issue, Jan Steele (Lucid co-founder and COO) talks to PME about the importance of demonstrating value with medical education via validated improvements in patient outcomes. Jan explains that...

New talent blooms at Lucid Group

Spring has most definitely sprung at Lucid Group as they welcome three new employees to their team. Laura Cunliffe joins as a Senior Account Manager at Leading Edge and will...

The art of changing behaviour with virtual technology

In April’s issue of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) explains how changing behaviour requires a combination of science and art. She outlines how the impact of...

Lucid CEO discusses the importance of company culture

In April’s Smart Thinking blog on pmlive.com, Dennis O’Brien (Lucid CEO) discusses company culture and how individual contribution is everything.Dennis explains that, despite organisations being obsessed with meeting financial targets every...